Krakow, Poland – November 12, 2020 – Ryvu Therapeutics (WSE:RVU), a clinical-stage biopharmaceutical company developing novel small molecule therapies that address emerging targets in oncology, announced today that the company will participate in the annual Jefferies Virtual London Healthcare Conference, taking place November 17-19, 2020.

The conference gathers public and private companies from the pharmaceuticals, biotechnology, medical technology, and healthcare services sectors worldwide. Participants can join the virtual platform, including chats, presentations, panels, organized meetings, and online social networking.

For additional information about the Jefferies Virtual Healthcare Conference, please visit: https://www.jefferies.com/IdeasAndPerspectives/Conferences/325/111720